125. Addictive Psych Meds | Beverley Thomson

125. Addictive Psych Meds | Beverley Thomson

Up next

The Doctor Who's Finally Studying Carnivore | Rob Abbott EP 229

In this episode, Dr. Robert Abbott, a clinician and researcher in functional medicine, joined me to discuss his role in what is set to become the largest study ever conducted on rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) using dietary intervention, specificall ...  Show more

How to Identify and Treat Mold Illness (CIRS) | Ariana Thacker EP 228

In this episode, I had a conversation with Ariana Thacker, founder and CEO of MoldCo, to discuss mold-related illness and Chronic Inflammatory Response Syndrome (CIRS). In 5-10 years everyone will know and understand how pervasive this is.Ariana shares her personal journey from c ...  Show more

Recommended Episodes

Ketamine Therapy for Treatment-Resistant Depression
Therapy in a Nutshell

If you have severe depression, PTSD, or anxiety that just won’t go away despite therapy and medication you should know about Ketamine. 30-40% of people with depression have treatment-resistant depression (that means that you’ve tried at least 2 types of medication and it isn't ...

  Show more

On Drugs: Antidepressants
Jacob Hawley: On Love

Comedian Jacob Hawley explores the UK drugs scene. This week he hears about the world of antidepressants: Are they overprescribed? How do they work? Who do they work for? He talks to his best mate Rebecca, and comedians Ahir Shah and Angela Barnes about their relationship to medi ...  Show more

Psychiatric Drugs
Betwixt The Sheets: The History of Sex, Scandal & Society

*WARNING this episode includes adult themes and conversations about mental health and drug use.*


In 2020, the UK government revealed that 17% of the adult population of Britain were prescribed medication for their mental health. But when were these drugs invented? Ho ...

  Show more

Depression und Antidepressiva: Fragliche Ursache, fragliche Wirkung
AMBOSS Podcast – Ärztliches Wissen für Klinik und Praxis

Monoaminmangelhypothese: Studienlage und alternative Erklärungsmodelle